Total Mytesi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jaguar Health, Inc. Reports 2021 First Quarter Financial Results ACCESSWIRE 17 May 2021, 22:05 GMT+10 First quarter 2021 Mytesi gross sales and net sales were approximately $4.6 million and approximately $1.2 million, increases of 250% and 43%, respectively Company to host investor webcast Monday, May 17th at 8:30 a.m. Eastern regarding first quarter 2021 financials & business updates SAN FRANCISCO, CA / ACCESSWIRE / May 17, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) today reported consolidated first quarter 2021 financial results. 2021 First Quarter Company Financial Results: Mytesi ® Net Product Revenue: Mytesi net sales during the first quarter of 2021 were approximately $1.2 million and $0.9 million in the first quarter of 2020. This first quarter 2021 result represents an increase of approximately 43% of the same period in 2020, or $0.3 million quarter over quarter. The increase in sales of Mytesi is due to the combined effect of the price adj

United statesPeter hodgeFirst quarter company financialJaguar health incNapo pharmaceuticals incJaguar healthQuarter company financial resultsNet product revenueWholesaler acquisition costGross product revenueMytesi prescription volumeTotal mytesiProduct revenueWarrant exercisePreferred stock amendment agreementSeriesb convertible preferred stock